Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 1:119:1-8.
doi: 10.1016/j.niox.2021.12.001. Epub 2021 Dec 4.

Capillary hemodynamics and contracting skeletal muscle oxygen pressures in male rats with heart failure: Impact of soluble guanylyl cyclase activator

Affiliations

Capillary hemodynamics and contracting skeletal muscle oxygen pressures in male rats with heart failure: Impact of soluble guanylyl cyclase activator

Ramona E Weber et al. Nitric Oxide. .

Abstract

In heart failure with reduced ejection fraction (HFrEF), nitric oxide-soluble guanylyl cyclase (sGC) pathway dysfunction impairs skeletal muscle arteriolar vasodilation and thus capillary hemodynamics, contributing to impaired oxygen uptake (V̇O2) kinetics. Targeting this pathway with sGC activators offers a new treatment approach to HFrEF. We tested the hypotheses that sGC activator administration would increase the O2 delivery (Q̇O2)-to-V̇O2 ratio in the skeletal muscle interstitial space (PO2is) of HFrEF rats during twitch contractions due, in part, to increases in red blood cell (RBC) flux (fRBC), velocity (VRBC), and capillary hematocrit (Hctcap). HFrEF was induced in male Sprague-Dawley rats via myocardial infarction. After 3 weeks, rats were treated with 0.3 mg/kg of the sGC activator BAY 60-2770 (HFrEF + BAY; n = 11) or solvent (HFrEF; n = 9) via gavage b.i.d for 5 days prior to phosphorescence quenching (PO2is, in contracting muscle) and intravital microscopy (resting) measurements in the spinotrapezius muscle. Intravital microscopy revealed higher fRBC (70 ± 9 vs 25 ± 8 RBC/s), VRBC (490 ± 43 vs 226 ± 35 μm/s), Hctcap (16 ± 1 vs 10 ± 1%) and a greater number of capillaries supporting flow (91 ± 3 vs 82 ± 3%) in HFrEF + BAY vs HFrEF (all P < 0.05). Additionally, PO2is was especially higher during 12-34s of contractions in HFrEF + BAY vs HFrEF (P < 0.05). Our findings suggest that sGC activators improved resting Q̇O2 via increased fRBC, VRBC, and Hctcap allowing for better Q̇O2-to-V̇O2 matching during the rest-contraction transient, supporting sGC activators as a potential therapeutic to target skeletal muscle vasomotor dysfunction in HFrEF.

Keywords: Exercise; Microcirculation; Nitric oxide; Oxygen transport.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.. Interstitial PO2 from rest to contractions in spinotrapezius muscle.
Data are means ± SE. Analyzed via two-way ANOVA (Group x Time). Group average spinotrapezius interstitial PO2 (PO2is) at rest and during electrically induced contractions for HFrEF + BAY (open circles; n = 10) and HFrEF (filled circles; n = 9); contractions beginning at 0s. *P < 0.05 (shaded area; 12–34 s).
Fig. 2.
Fig. 2.. Capillary hemodynamics in spinotrapezius muscle at rest.
Data are means ± SE. Analyzed via student’s unpaired t-test. A. RBC flux in skeletal muscle capillaries supporting flow. B. RBC velocity in skeletal muscle capillaries supporting flow. C. Capillary hematocrit in skeletal muscle capillaries. D. Percentage of capillaries supporting RBC flow. HFrEF + BAY n = 9; HFrEF n = 8; all * P < 0.05.
Fig. 3.
Fig. 3.. Relationship between average RBC velocity and flux in capillaries supporting continuous flow in HFrEF + BAY and HFrEF
(P < 0.05).
Fig. 4.
Fig. 4.. Western immunoblotting.
Data are means ± SE. A. Normalized protein expression in HFrEF (n = 8) vs HFrEF + BAY (n = 10) (P > 0.05). B. Representative blotting of sGCβ1 expression in HFrEF vs HFrEF + BAY.

Similar articles

Cited by

References

    1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain A, Chang A, Chang S, Das S, Delling F, Djousse L, Ferguson J, Fornage M, Jordan L, Khan S, Kissela B, Knutson K, Kwan T, Lackland D, Lewis T, Lichtman J, Longenecker C, Loop M, Lutsey P, Martin S, Matsushita K, Moran A, Mussolino M, O’Flaherty M, Pandry A, Perak A, Rosamond W, Roth G, Sampson U, Satou G, Schroeder E, Shah S, Spartano N, Stokes A, Tirschwell D, Tsao C, Turakhia M, VanWagner L, Wilkins J, Wong S, Virani S, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, Heart disease and stroke statistics—2019 update: a report from the American Heart Association, Circulation 139 (10) (2019) e56–e528, 2019. - PubMed
    1. Poole DC, Hirai DM, Copp SW, Musch TI, Muscle oxygen transport and utilization in heart failure: implications for exercise (in) tolerance, Am. J. Physiol. Heart Circ. Physiol 302 (5) (2012) H1050–H1063. - PMC - PubMed
    1. Weber KT, Kinasewitz GT, Janicki JS, Fishman AP, Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure, Circulation 65 (6) (1982) 1213–1223. - PubMed
    1. Crespo-Leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, Gustafsson F, Tsui S, Barge-Caballero E, De Jonge N, Frigerio M, Hamdan R, Hasin T, Hülsmann M, Nalbantgil S, Potena L, Bauersachs J, Gkouziouta A, Ruhparwar A, Ristic AD, Straburzynska-Migaj E, Mcdonagh T, Serferovic P, Ruschitzka F, Advanced heart failure: a position statement of the heart failure association of the European society of cardiology, Eur. J. Heart Fail 20 (11) (2018) 1505–1535. - PubMed
    1. Drexler H, Hayoz D, Münzel T, Hornig B, Just H, Brunner HR, Zelis R, Endothelial function in chronic congestive heart failure, Am. J. Cardiol 69 (19) (1992) 1596–1601. - PubMed

Publication types

Substances